0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Law/Legislation
 21-40 of 721 Articles
JAMA | 
Viewpoint | 
Kenneth W. Lin, MD, MPH; Lawrence O. Gostin, JD
JAMA. 2016;315(10):977-978. doi:10.1001/jama.2016.0322.

JAMA Pediatrics | 
Viewpoint |  ONLINE FIRST
Andrea J. Hoopes, MD, MPH; Gina S. Sucato, MD, MPH; Douglas S. Diekema, MD, MPH
JAMA Pediatr. Published online March 07, 2016. doi:10.1001/jamapediatrics.2015.3152

JAMA Oncology | 
Editorial |  ONLINE FIRST
Gary H. Lyman, MD, MPH
JAMA Oncol. Published online March 03, 2016. doi:10.1001/jamaoncol.2015.6477

JAMA Internal Medicine | 
Viewpoint | 
Amy Kapczynski, JD
JAMA Intern Med. 2016;176(3):295-296. doi:10.1001/jamainternmed.2015.8155.

JAMA Pediatrics | 
Viewpoint | 
Sharon Levy, MD, MPH; Elissa R. Weitzman, ScD, MSc
JAMA Pediatr. 2016;170(3):193-194. doi:10.1001/jamapediatrics.2015.3489.

JAMA Oncology | 
Viewpoint | 
Daniel M. Geynisman, MD; Yu-Ning Wong, MD, MSCE
JAMA Oncol. 2016;2(3):295-296. doi:10.1001/jamaoncol.2015.5345.

JAMA Ophthalmology | 
Original Investigation | 
David A. Belyea, MD, MBA; Rashed Alhabshan, MD; Ana Maria del Rio-Gonzalez, PhD; et al.
JAMA Ophthalmol. 2016;134(3):259-264. doi:10.1001/jamaophthalmol.2015.5209.
Includes: Supplemental Content

JAMA | 
Viewpoint | 
Mary C. Politi, PhD; Adam Sonfield, MPP; Tessa Madden, MD, MPH
JAMA. 2016;315(7):653-654. doi:10.1001/jama.2016.0204.

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(6):549. doi:10.1001/jama.2016.0162.

JAMA | 
The JAMA Forum |  FREE
Lawrence O. Gostin, JD
JAMA. 2016;315(5):453-454. doi:10.1001/jama.2015.19497.

JAMA | 
Viewpoint | 
Jeremy A. Greene, MD, PhD; Gerard Anderson, PhD; Joshua M. Sharfstein, MD
JAMA. 2016;315(5):461-462. doi:10.1001/jama.2015.18720.

JAMA Dermatology | 
Viewpoint | 
Walter Liszewski, MD; Jared Jagdeo, MD, MS; Anne E. Laumann, MBChB, MRCP (UK)
JAMA Dermatol. 2016;152(2):141-142. doi:10.1001/jamadermatol.2015.4000.

JAMA Pediatrics | 
Research Letter | 
Jeffrey D. Colvin, MD, JD; Matt Hall, PhD; Laura Gottlieb, MD, MPH; et al.
JAMA Pediatr. 2016;170(2):176-178. doi:10.1001/jamapediatrics.2015.3366.

JAMA Oncology | 
Editorial | 
Clarisa R. Gracia, MD, MSCE; Susan L. Crockin, JD
JAMA Oncol. 2016;2(2):182-184. doi:10.1001/jamaoncol.2015.5611.

JAMA Oncology | 
Special Communication | 
Ehren M. Fournier, JD
JAMA Oncol. 2016;2(2):249-252. doi:10.1001/jamaoncol.2015.5610.

JAMA | 
Viewpoint | 
Ryan P. Clodfelter, BA; Eli Y. Adashi, MD, MS
JAMA. 2016;315(3):251-252. doi:10.1001/jama.2015.16242.

JAMA | 
Viewpoint | 
Kendra A. Moore, BA; Emily B. Rubin, MD, JD; Scott D. Halpern, MD, PhD
JAMA. 2016;315(3):259-260. doi:10.1001/jama.2015.17362.

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(2):122. doi:10.1001/jama.2015.17457.

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(2):122. doi:10.1001/jama.2015.18244.

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(2):122. doi:10.1001/jama.2015.18251.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Updating the Toxic Substances Control Act to Protect Human Health
Leonardo Trasande, MD, MPP
JAMA
Viewpoint  | 
Pharmacist-Prescribed Birth Control in Oregon and Other States
Y. Tony Yang, ScD, LLM, MPH; Katy B. Kozhimannil, PhD, MPA; Jonathan M. Snowden, PhD
JAMA
Capitol Health Call  | 
Bill Would Permit Partial Filling of Opioid Prescriptions
Rita Rubin, MA
JAMA
Research Letter  | 
Physicians’ Knowledge About FDA Approval Standards and Perceptions of the “Breakthrough Therapy” Designation
Aaron S. Kesselheim, MD, JD, MPH; Steven Woloshin, MD, MS; Wesley Eddings, PhD; et al.